The amount of immune cell infiltration in low-risk patients was significantly higher than that in high-risk patients, and included cell types such as B cells, CD4+ T cells, macrophages, Th cells, and tumor-infiltrating lymphocytes (TILs). The gene discussed is CD4; the disease is neoplasm.